Team:Yale/Results
From 2014.igem.org
Line 133: | Line 133: | ||
<ol type="I"> | <ol type="I"> | ||
- | <li><strong>T7 RNA polymerase design and creation</strong><p> | + | <li><strong>T7 RNA polymerase design and creation</strong> |
+ | <p> | ||
The T7 Riboregulation System works by a “three-lock system.” The first lock is the cis- repressing RNA (crRNA), which is induced bysopropyl β-D-1-thiogalactopyranoside (IPTG). The second lock is the trans-activating RNA (taRNA), which is induced by anhydrous tetracycline (ATC). If the taRNA is unlocked, it will bind to the crRNA, removing the hairpin and making the ribosomal binding site accessible for ribosomal binding, leading to translation of a specific protein, in this case, T7 RNA Polymerase. This system was initially developed by Dr. Farren Isaacs, and has been shown to work with chloramphenicol resistance (chloramphenical acetyl transferase gene) in place of the T7 gene. The plasmid was synthesized via Gibson assembly, and confirmed by sequencing. | The T7 Riboregulation System works by a “three-lock system.” The first lock is the cis- repressing RNA (crRNA), which is induced bysopropyl β-D-1-thiogalactopyranoside (IPTG). The second lock is the trans-activating RNA (taRNA), which is induced by anhydrous tetracycline (ATC). If the taRNA is unlocked, it will bind to the crRNA, removing the hairpin and making the ribosomal binding site accessible for ribosomal binding, leading to translation of a specific protein, in this case, T7 RNA Polymerase. This system was initially developed by Dr. Farren Isaacs, and has been shown to work with chloramphenicol resistance (chloramphenical acetyl transferase gene) in place of the T7 gene. The plasmid was synthesized via Gibson assembly, and confirmed by sequencing. | ||
Line 152: | Line 153: | ||
<li><strong>Functional Assays for Riboregulated T7 system</strong> | <li><strong>Functional Assays for Riboregulated T7 system</strong> | ||
- | <p> | + | <p> |
- | <p> | + | Experimental plan for the GFP fluorescence assay testing the efficacy of the T7 riboregulation system. The T7 riboregulation system, pZE21_A12C_T7RNA, would express sfGFP behind a T7 promoter, in the plasmid pZA21. Either plasmid, and both plasmids together, were transformed into ECNR2 and induced with either IPTG and ATC. ECNR2 is the ancestral strain. A positive control was the same pZA21_T7sfGFP plasmid in ECNR2, and the same T7 RNA polymerase gene inserted in a regular pZE21 plasmid with a pLtetO promoter, and a negative control with the pZA21_T7sfGFP in ECNR2 without any plasmid that contains T7 RNA.</p> |
- | <p> | + | |
+ | <img src="https://static.igem.org/mediawiki/2014/f/ff/Yale_figure8.png"> | ||
+ | |||
+ | <p> | ||
+ | <center> | ||
+ | <i><strong>Figure 3.</strong> The functionalities behind the GFP assay.</i></center></p> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2014/0/03/Yale_figure9.png"> | ||
+ | |||
+ | <p> | ||
+ | <center> | ||
+ | <i><strong>Figure 4.</strong> Conformational assay to test the functionality of the pZA21_T7sfGFP, which is sfGFP placed behind the T7 promoter. The plasmid was transformed into a BL21(DE3) strain, which constitutively expresses T7 RNA polymerase. The strain, as well as untransformed BL21(DE3), were grown overnight and assayed using a Synergy H1 Biotek Platereader. </i></center></p> | ||
+ | |||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2014/3/37/Yale_table_1.png"> | ||
+ | |||
+ | <p> | ||
+ | <center> | ||
+ | <i><strong>Table 1.</strong> Experimental conditions for the GFP assay. Each plasmid combination was paired with each inducer combination, and the conditions were made in sextuplicate.</i></center></p> | ||
+ | |||
+ | |||
</tr> | </tr> | ||
<tr> | <tr> |
Revision as of 03:02, 18 October 2014
Results |
|||||||||||
T7 Riboregulation System
| |||||||||||
Adhesion Testing
|